![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 3191 |
FusionGeneSummary for ATG5_AK9 |
![]() |
Fusion gene information | Fusion gene name: ATG5_AK9 | Fusion gene ID: 3191 | Hgene | Tgene | Gene symbol | ATG5 | AK9 | Gene ID | 9474 | 221264 |
Gene name | autophagy related 5 | adenylate kinase 9 | |
Synonyms | APG5|APG5-LIKE|APG5L|ASP|SCAR25|hAPG5 | AK 9|AKD1|AKD2|C6orf199|C6orf224|dJ70A9.1 | |
Cytomap | 6q21 | 6q21 | |
Type of gene | protein-coding | protein-coding | |
Description | autophagy protein 5APG5 autophagy 5-likeATG5 autophagy related 5 homologapoptosis-specific protein | adenylate kinase 9adenylate kinase domain containing 1adenylate kinase domain containing 2 | |
Modification date | 20180527 | 20180519 | |
UniProtAcc | Q9H1Y0 | Q5TCS8 | |
Ensembl transtripts involved in fusion gene | ENST00000343245, ENST00000369070, ENST00000369076, ENST00000360666, ENST00000475645, | ENST00000424296, ENST00000341338, ENST00000368948, ENST00000285397, ENST00000355283, | |
Fusion gene scores | * DoF score | 16 X 8 X 9=1152 | 2 X 2 X 1=4 |
# samples | 16 | 2 | |
** MAII score | log2(16/1152*10)=-2.84799690655495 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(2/4*10)=2.32192809488736 | |
Context | PubMed: ATG5 [Title/Abstract] AND AK9 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation | Kinase involved fusion gene, inframe and retained kinase domain. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Tgene | AK9 | GO:0006174 | dADP phosphorylation | 23416111 |
Tgene | AK9 | GO:0006186 | dGDP phosphorylation | 23416111 |
Tgene | AK9 | GO:0006756 | AMP phosphorylation | 23416111 |
Tgene | AK9 | GO:0006757 | ATP generation from ADP | 23416111 |
Tgene | AK9 | GO:0061508 | CDP phosphorylation | 23416111 |
Tgene | AK9 | GO:0061565 | dAMP phosphorylation | 23416111 |
Tgene | AK9 | GO:0061566 | CMP phosphorylation | 23416111 |
Tgene | AK9 | GO:0061567 | dCMP phosphorylation | 23416111 |
Tgene | AK9 | GO:0061568 | GDP phosphorylation | 23416111 |
Tgene | AK9 | GO:0061569 | UDP phosphorylation | 23416111 |
Tgene | AK9 | GO:0061570 | dCDP phosphorylation | 23416111 |
Tgene | AK9 | GO:0061571 | TDP phosphorylation | 23416111 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | LD | BRCA | TCGA-EW-A6S9-01A | ATG5 | chr6 | 106696025 | - | AK9 | chr6 | 109980616 | - |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
In-frame | ENST00000343245 | ENST00000424296 | ATG5 | chr6 | 106696025 | - | AK9 | chr6 | 109980616 | - |
5CDS-5UTR | ENST00000343245 | ENST00000341338 | ATG5 | chr6 | 106696025 | - | AK9 | chr6 | 109980616 | - |
5CDS-5UTR | ENST00000343245 | ENST00000368948 | ATG5 | chr6 | 106696025 | - | AK9 | chr6 | 109980616 | - |
5CDS-5UTR | ENST00000343245 | ENST00000285397 | ATG5 | chr6 | 106696025 | - | AK9 | chr6 | 109980616 | - |
5CDS-intron | ENST00000343245 | ENST00000355283 | ATG5 | chr6 | 106696025 | - | AK9 | chr6 | 109980616 | - |
Frame-shift | ENST00000369070 | ENST00000424296 | ATG5 | chr6 | 106696025 | - | AK9 | chr6 | 109980616 | - |
5CDS-5UTR | ENST00000369070 | ENST00000341338 | ATG5 | chr6 | 106696025 | - | AK9 | chr6 | 109980616 | - |
5CDS-5UTR | ENST00000369070 | ENST00000368948 | ATG5 | chr6 | 106696025 | - | AK9 | chr6 | 109980616 | - |
5CDS-5UTR | ENST00000369070 | ENST00000285397 | ATG5 | chr6 | 106696025 | - | AK9 | chr6 | 109980616 | - |
5CDS-intron | ENST00000369070 | ENST00000355283 | ATG5 | chr6 | 106696025 | - | AK9 | chr6 | 109980616 | - |
Frame-shift | ENST00000369076 | ENST00000424296 | ATG5 | chr6 | 106696025 | - | AK9 | chr6 | 109980616 | - |
5CDS-5UTR | ENST00000369076 | ENST00000341338 | ATG5 | chr6 | 106696025 | - | AK9 | chr6 | 109980616 | - |
5CDS-5UTR | ENST00000369076 | ENST00000368948 | ATG5 | chr6 | 106696025 | - | AK9 | chr6 | 109980616 | - |
5CDS-5UTR | ENST00000369076 | ENST00000285397 | ATG5 | chr6 | 106696025 | - | AK9 | chr6 | 109980616 | - |
5CDS-intron | ENST00000369076 | ENST00000355283 | ATG5 | chr6 | 106696025 | - | AK9 | chr6 | 109980616 | - |
Frame-shift | ENST00000360666 | ENST00000424296 | ATG5 | chr6 | 106696025 | - | AK9 | chr6 | 109980616 | - |
5CDS-5UTR | ENST00000360666 | ENST00000341338 | ATG5 | chr6 | 106696025 | - | AK9 | chr6 | 109980616 | - |
5CDS-5UTR | ENST00000360666 | ENST00000368948 | ATG5 | chr6 | 106696025 | - | AK9 | chr6 | 109980616 | - |
5CDS-5UTR | ENST00000360666 | ENST00000285397 | ATG5 | chr6 | 106696025 | - | AK9 | chr6 | 109980616 | - |
5CDS-intron | ENST00000360666 | ENST00000355283 | ATG5 | chr6 | 106696025 | - | AK9 | chr6 | 109980616 | - |
intron-3CDS | ENST00000475645 | ENST00000424296 | ATG5 | chr6 | 106696025 | - | AK9 | chr6 | 109980616 | - |
intron-5UTR | ENST00000475645 | ENST00000341338 | ATG5 | chr6 | 106696025 | - | AK9 | chr6 | 109980616 | - |
intron-5UTR | ENST00000475645 | ENST00000368948 | ATG5 | chr6 | 106696025 | - | AK9 | chr6 | 109980616 | - |
intron-5UTR | ENST00000475645 | ENST00000285397 | ATG5 | chr6 | 106696025 | - | AK9 | chr6 | 109980616 | - |
intron-intron | ENST00000475645 | ENST00000355283 | ATG5 | chr6 | 106696025 | - | AK9 | chr6 | 109980616 | - |
Top |
FusionProtFeatures for ATG5_AK9 |
![]() |
Hgene | Tgene |
ATG5 | AK9 |
Involved in autophagic vesicle formation. Conjugationwith ATG12, through a ubiquitin-like conjugating system involvingATG7 as an E1-like activating enzyme and ATG10 as an E2-likeconjugating enzyme, is essential for its function. The ATG12-ATG5conjugate acts as an E3-like enzyme which is required forlipidation of ATG8 family proteins and their association to thevesicle membranes. Involved in mitochondrial quality control afteroxidative damage, and in subsequent cellular longevity. Plays acritical role in multiple aspects of lymphocyte development and isessential for both B and T lymphocyte survival and proliferation.Required for optimal processing and presentation of antigens forMHC II. Involved in the maintenance of axon morphology andmembrane structures, as well as in normal adipocytedifferentiation. Promotes primary ciliogenesis through removal ofOFD1 from centriolar satellites and degradation of IFT20 via theautophagic pathway. {ECO:0000250|UniProtKB:Q99J83,ECO:0000269|PubMed:12207896, ECO:0000269|PubMed:20580051,ECO:0000269|PubMed:22170153, ECO:0000269|PubMed:26812546}. May play an important role in the apoptotic process,possibly within the modified cytoskeleton. Its expression is arelatively late event in the apoptotic process, occurringdownstream of caspase activity. Plays a crucial role in IFN-gamma-induced autophagic cell death by interacting with FADD.{ECO:0000269|PubMed:15778222, ECO:0000269|PubMed:7796880}. (Microbial infection) May act as a proviral factor. Inassociation with ATG12, negatively regulates the innate antiviralimmune response by impairing the type I IFN production pathwayupon vesicular stomatitis virus (VSV) infection (PubMed:17709747).Required for the translation of incoming hepatitis C virus (HCV)RNA and, thereby, for initiation of HCV replication, but notrequired once infection is established (PubMed:19666601).{ECO:0000269|PubMed:17709747, ECO:0000269|PubMed:19666601}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | >AK9 | chr6:106696025 | chr6:109980616 | ENST00000285397 | - | 5 | 12 | 443_485 | 148 | 422 | Coiled coil | Ontology_term=ECO:0000255 |
Tgene | >AK9 | chr6:106696025 | chr6:109980616 | ENST00000285397 | - | 5 | 12 | 676_711 | 148 | 422 | Coiled coil | Ontology_term=ECO:0000255 |
Tgene | >AK9 | chr6:106696025 | chr6:109980616 | ENST00000355283 | - | 0 | 5 | 443_485 | -83 | 337 | Coiled coil | Ontology_term=ECO:0000255 |
Tgene | >AK9 | chr6:106696025 | chr6:109980616 | ENST00000355283 | - | 0 | 5 | 676_711 | -83 | 337 | Coiled coil | Ontology_term=ECO:0000255 |
Tgene | >AK9 | chr6:106696025 | chr6:109980616 | ENST00000424296 | - | 5 | 41 | 443_485 | 148 | 1912 | Coiled coil | Ontology_term=ECO:0000255 |
Tgene | >AK9 | chr6:106696025 | chr6:109980616 | ENST00000424296 | - | 5 | 41 | 676_711 | 148 | 1912 | Coiled coil | Ontology_term=ECO:0000255 |
Tgene | >AK9 | chr6:106696025 | chr6:109980616 | ENST00000285397 | - | 5 | 12 | 198_275 | 148 | 422 | Compositional bias | Note=Glu-rich |
Tgene | >AK9 | chr6:106696025 | chr6:109980616 | ENST00000355283 | - | 0 | 5 | 198_275 | -83 | 337 | Compositional bias | Note=Glu-rich |
Tgene | >AK9 | chr6:106696025 | chr6:109980616 | ENST00000424296 | - | 5 | 41 | 198_275 | 148 | 1912 | Compositional bias | Note=Glu-rich |
Tgene | >AK9 | chr6:106696025 | chr6:109980616 | ENST00000285397 | - | 5 | 12 | 1001_1006 | 148 | 422 | Nucleotide binding | ATP 2 |
Tgene | >AK9 | chr6:106696025 | chr6:109980616 | ENST00000285397 | - | 5 | 12 | 1050_1052 | 148 | 422 | Nucleotide binding | AMP 2 |
Tgene | >AK9 | chr6:106696025 | chr6:109980616 | ENST00000285397 | - | 5 | 12 | 1079_1082 | 148 | 422 | Nucleotide binding | AMP 2 |
Tgene | >AK9 | chr6:106696025 | chr6:109980616 | ENST00000285397 | - | 5 | 12 | 1421_1426 | 148 | 422 | Nucleotide binding | ATP 3 |
Tgene | >AK9 | chr6:106696025 | chr6:109980616 | ENST00000285397 | - | 5 | 12 | 1470_1472 | 148 | 422 | Nucleotide binding | AMP 3 |
Tgene | >AK9 | chr6:106696025 | chr6:109980616 | ENST00000285397 | - | 5 | 12 | 1499_1502 | 148 | 422 | Nucleotide binding | AMP 3 |
Tgene | >AK9 | chr6:106696025 | chr6:109980616 | ENST00000355283 | - | 0 | 5 | 1001_1006 | -83 | 337 | Nucleotide binding | ATP 2 |
Tgene | >AK9 | chr6:106696025 | chr6:109980616 | ENST00000355283 | - | 0 | 5 | 1050_1052 | -83 | 337 | Nucleotide binding | AMP 2 |
Tgene | >AK9 | chr6:106696025 | chr6:109980616 | ENST00000355283 | - | 0 | 5 | 1079_1082 | -83 | 337 | Nucleotide binding | AMP 2 |
Tgene | >AK9 | chr6:106696025 | chr6:109980616 | ENST00000355283 | - | 0 | 5 | 116_119 | -83 | 337 | Nucleotide binding | AMP 1 |
Tgene | >AK9 | chr6:106696025 | chr6:109980616 | ENST00000355283 | - | 0 | 5 | 1421_1426 | -83 | 337 | Nucleotide binding | ATP 3 |
Tgene | >AK9 | chr6:106696025 | chr6:109980616 | ENST00000355283 | - | 0 | 5 | 1470_1472 | -83 | 337 | Nucleotide binding | AMP 3 |
Tgene | >AK9 | chr6:106696025 | chr6:109980616 | ENST00000355283 | - | 0 | 5 | 1499_1502 | -83 | 337 | Nucleotide binding | AMP 3 |
Tgene | >AK9 | chr6:106696025 | chr6:109980616 | ENST00000355283 | - | 0 | 5 | 40_45 | -83 | 337 | Nucleotide binding | ATP 1 |
Tgene | >AK9 | chr6:106696025 | chr6:109980616 | ENST00000355283 | - | 0 | 5 | 87_89 | -83 | 337 | Nucleotide binding | AMP 1 |
Tgene | >AK9 | chr6:106696025 | chr6:109980616 | ENST00000424296 | - | 5 | 41 | 1001_1006 | 148 | 1912 | Nucleotide binding | ATP 2 |
Tgene | >AK9 | chr6:106696025 | chr6:109980616 | ENST00000424296 | - | 5 | 41 | 1050_1052 | 148 | 1912 | Nucleotide binding | AMP 2 |
Tgene | >AK9 | chr6:106696025 | chr6:109980616 | ENST00000424296 | - | 5 | 41 | 1079_1082 | 148 | 1912 | Nucleotide binding | AMP 2 |
Tgene | >AK9 | chr6:106696025 | chr6:109980616 | ENST00000424296 | - | 5 | 41 | 1421_1426 | 148 | 1912 | Nucleotide binding | ATP 3 |
Tgene | >AK9 | chr6:106696025 | chr6:109980616 | ENST00000424296 | - | 5 | 41 | 1470_1472 | 148 | 1912 | Nucleotide binding | AMP 3 |
Tgene | >AK9 | chr6:106696025 | chr6:109980616 | ENST00000424296 | - | 5 | 41 | 1499_1502 | 148 | 1912 | Nucleotide binding | AMP 3 |
Tgene | >AK9 | chr6:106696025 | chr6:109980616 | ENST00000285397 | - | 5 | 12 | 1021_1052 | 148 | 422 | Region | NMPbind 2 |
Tgene | >AK9 | chr6:106696025 | chr6:109980616 | ENST00000285397 | - | 5 | 12 | 1124_1144 | 148 | 422 | Region | LID 2 |
Tgene | >AK9 | chr6:106696025 | chr6:109980616 | ENST00000285397 | - | 5 | 12 | 1412_1601 | 148 | 422 | Region | Adenylate kinase 3 |
Tgene | >AK9 | chr6:106696025 | chr6:109980616 | ENST00000285397 | - | 5 | 12 | 1441_1472 | 148 | 422 | Region | NMPbind 3 |
Tgene | >AK9 | chr6:106696025 | chr6:109980616 | ENST00000285397 | - | 5 | 12 | 1536_1550 | 148 | 422 | Region | LID 3 |
Tgene | >AK9 | chr6:106696025 | chr6:109980616 | ENST00000285397 | - | 5 | 12 | 160_205 | 148 | 422 | Region | LID 1 |
Tgene | >AK9 | chr6:106696025 | chr6:109980616 | ENST00000285397 | - | 5 | 12 | 992_1203 | 148 | 422 | Region | Adenylate kinase 2 |
Tgene | >AK9 | chr6:106696025 | chr6:109980616 | ENST00000355283 | - | 0 | 5 | 1021_1052 | -83 | 337 | Region | NMPbind 2 |
Tgene | >AK9 | chr6:106696025 | chr6:109980616 | ENST00000355283 | - | 0 | 5 | 1124_1144 | -83 | 337 | Region | LID 2 |
Tgene | >AK9 | chr6:106696025 | chr6:109980616 | ENST00000355283 | - | 0 | 5 | 1412_1601 | -83 | 337 | Region | Adenylate kinase 3 |
Tgene | >AK9 | chr6:106696025 | chr6:109980616 | ENST00000355283 | - | 0 | 5 | 1441_1472 | -83 | 337 | Region | NMPbind 3 |
Tgene | >AK9 | chr6:106696025 | chr6:109980616 | ENST00000355283 | - | 0 | 5 | 1536_1550 | -83 | 337 | Region | LID 3 |
Tgene | >AK9 | chr6:106696025 | chr6:109980616 | ENST00000355283 | - | 0 | 5 | 160_205 | -83 | 337 | Region | LID 1 |
Tgene | >AK9 | chr6:106696025 | chr6:109980616 | ENST00000355283 | - | 0 | 5 | 31_285 | -83 | 337 | Region | Adenylate kinase 1 |
Tgene | >AK9 | chr6:106696025 | chr6:109980616 | ENST00000355283 | - | 0 | 5 | 60_89 | -83 | 337 | Region | NMPbind 1 |
Tgene | >AK9 | chr6:106696025 | chr6:109980616 | ENST00000355283 | - | 0 | 5 | 992_1203 | -83 | 337 | Region | Adenylate kinase 2 |
Tgene | >AK9 | chr6:106696025 | chr6:109980616 | ENST00000424296 | - | 5 | 41 | 1021_1052 | 148 | 1912 | Region | NMPbind 2 |
Tgene | >AK9 | chr6:106696025 | chr6:109980616 | ENST00000424296 | - | 5 | 41 | 1124_1144 | 148 | 1912 | Region | LID 2 |
Tgene | >AK9 | chr6:106696025 | chr6:109980616 | ENST00000424296 | - | 5 | 41 | 1412_1601 | 148 | 1912 | Region | Adenylate kinase 3 |
Tgene | >AK9 | chr6:106696025 | chr6:109980616 | ENST00000424296 | - | 5 | 41 | 1441_1472 | 148 | 1912 | Region | NMPbind 3 |
Tgene | >AK9 | chr6:106696025 | chr6:109980616 | ENST00000424296 | - | 5 | 41 | 1536_1550 | 148 | 1912 | Region | LID 3 |
Tgene | >AK9 | chr6:106696025 | chr6:109980616 | ENST00000424296 | - | 5 | 41 | 160_205 | 148 | 1912 | Region | LID 1 |
Tgene | >AK9 | chr6:106696025 | chr6:109980616 | ENST00000424296 | - | 5 | 41 | 992_1203 | 148 | 1912 | Region | Adenylate kinase 2 |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000285397 | - | 5 | 12 | 116_119 | 148 | 422 | Nucleotide binding | AMP 1 |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000285397 | - | 5 | 12 | 40_45 | 148 | 422 | Nucleotide binding | ATP 1 |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000285397 | - | 5 | 12 | 87_89 | 148 | 422 | Nucleotide binding | AMP 1 |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000424296 | - | 5 | 41 | 116_119 | 148 | 1912 | Nucleotide binding | AMP 1 |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000424296 | - | 5 | 41 | 40_45 | 148 | 1912 | Nucleotide binding | ATP 1 |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000424296 | - | 5 | 41 | 87_89 | 148 | 1912 | Nucleotide binding | AMP 1 |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000285397 | - | 5 | 12 | 31_285 | 148 | 422 | Region | Adenylate kinase 1 |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000285397 | - | 5 | 12 | 60_89 | 148 | 422 | Region | NMPbind 1 |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000424296 | - | 5 | 41 | 31_285 | 148 | 1912 | Region | Adenylate kinase 1 |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000424296 | - | 5 | 41 | 60_89 | 148 | 1912 | Region | NMPbind 1 |
Top |
FusionGeneSequence for ATG5_AK9 |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
>In-frame_ATG5_ENST00000343245_chr6_106696025_-_AK9_ENST00000424296_chr6_109980616_-_1955aa MTDDKDVLRDVWFGRIPTCFTLYQDEITEREAEPYYLLLPRVSYLTLVTDKVKKHFQKVMRQEDISEIWFEYEGTPLKWHYPIGLLFDLL ASSSALPWNITVHFKSFPEKDLLHCPSKDAIEAHFMSCMKEADALKHKSQVINEMQKKDHKQLWMGLQNDRFDQFWAINRKLMEYPAEEN GFRYIPFRIYQCPDYDLCQRISGQRQHNNTGYIYSRDQWDPEVIENHRKKKKEAQKDGKGEEEEEEEEQEEEEAFIAEMQMVAEILHHLV QRPEDYLENVENIVKLYKETILQTLEEVMAEHNPQYLIELNGNKPAEELFMIVMDRLKYLNLKRAAILTKLQGAEEEINDTMENDELFRT LASYKLIAPRYRWQRSKWGRTCPVNLKDGNIYSGLPDYSVSFLGKIYCLSSEEALKPFLLNPRPYLLPPMPGPPCKVFILGPQYSGKTTL CNMLAENYKGKVVDYAQLVQPRFDKARETLVENTIAEATAAAIKVVKEKLLRELQARKQAETALREFQRQYEKMEFGVFPMEATHSSIDE EGYIQGSQRDRGSSLVDTEEAKTKSENVLHDQAAKVDKDDGKETGETFTFKRHSQDASQDVKLYSDTAPTEDLIEEVTADHPEVVTMIEE TIKMSQDINFEQPYEKHAEILQEVLGEVMEENKDRFPGAPKYGGWIVDNCPIVKELWMALIKKGIIPDLVIYLSDTENNGKCLFNRIYLQ KKSEIDSKILERLLEELQKKKKEEEEARKATEEELRLEEENRRLLELMKVKAKEAEETDNEDEEEIEGDELEVHEEPEASHDTRGSWLPE EFEASEVPETEPEAVSEPIEETTVETEIPKGSKEGLEIEKLSETVVLPEFPEDSYPDVPEMEPFKEKIGSFIILWKQLEATISEAYIKIL NLEIADRTPQELLQKVVETMEKPFQYTAWELTGEDYEEETEDYQTEAEVDEELEEEEEEEGEDKMKERKRHLGDTKHFCPVVLKENFILQ PGNTEEAAKYREKIYYFSSAEAKEKFLEHPEDYVAHEEPLKAPPLRICLVGPQGSGKTMCGRQLAEKLNIFHIQFEEVLQEKLLLKTEKK VGPEFEEDSENEQAAKQELEELAIQANVKVEEENTKKQLPEVQLTEEEEVIKSSLMENEPLPPEILEVILSEWWLKEPIRSTGFILDGFP RYPEEAQFLGDRGFFPDAAVFIQVDDQDIFDRLLPAQIEKWKLKQKKKLERKKLIKDMKAKIRVDTIAKRRAELILERDKKRRENVVRDD EEISEEELEEDNDDIENILEDEFPKDEEEMSGEEDEEQETDAIERLRGELGEKFEADTHNLQIIQDELERYLIPIISINGARRNHIVQYT LNMKLKPLVENRASIFEKCHPIPAPLAQKMLTFTYKYISSFGYWDPVKLSEGETIKPVENAENPIYPVIHRQYIYFLSSKETKEKFMKNP IKYIRQPKPKPTVPIRIIIVGPPKSGKTTVAKKITSEYGLKHLSIGGALRYVLNNHPETELALMLNWHLHKGMTAPDELAIQALELSLME SVCNTAGVVIDGYPVTKHQMNLLEARSIIPMVIFELSVPSKEIFKRLLLEKENEQRLPYPLHNSAQIVAVNNVKYRKNIGEIRQYYQEQH QNWYVIDGFHSKWWVWNEVIKNVQMVNKYMQTYLERIKAGKAACIDKLCITPQELLSRLGEFEQFCPVSLAESQELFDCSATDSLEFAAE FRGHYYKMSSQEKLNKFLENPELYVPPLAPHPLPSADMIPKRLTLSELKSRFPKCAELQGYCPVTYKDGNQRYEALVPGSINYALEYHNR IYICENKEKLQKFLRSPLKYWEQKLPHKLPPLREPILLTSLPLPGYLEQGIATSLIKAMNAAGCLKPKFPFLSIRRSALLYIALHLKAFN |
* Fusion transcript sequences (only coding sequence (CDS) region). |
>In-frame_ATG5_ENST00000343245_chr6_106696025_-_AK9_ENST00000424296_chr6_109980616_-_5865nt ATGACAGATGACAAAGATGTGCTTCGAGATGTGTGGTTTGGACGAATTCCAACTTGTTTCACGCTATATCAGGATGAGATAACTGAAAGG GAAGCAGAACCATACTATTTGCTTTTGCCAAGAGTAAGTTATTTGACGTTGGTAACTGACAAAGTGAAAAAGCACTTTCAGAAGGTTATG AGACAAGAAGACATTAGTGAGATATGGTTTGAATATGAAGGCACACCACTGAAATGGCATTATCCAATTGGTTTGCTATTTGATCTTCTT GCATCAAGTTCAGCTCTTCCTTGGAACATCACAGTACATTTTAAGAGTTTTCCAGAAAAAGACCTTCTGCACTGTCCATCTAAGGATGCA ATTGAAGCTCATTTTATGTCATGTATGAAAGAAGCTGATGCTTTAAAACATAAAAGTCAAGTAATCAATGAAATGCAGAAAAAAGATCAC AAGCAACTCTGGATGGGATTGCAAAATGACAGATTTGACCAGTTTTGGGCCATCAATCGGAAACTCATGGAATATCCTGCAGAAGAAAAT GGATTTCGTTATATCCCCTTTAGAATATATCAGTGTCCTGACTATGATTTGTGCCAGAGAATTTCTGGGCAAAGACAGCACAATAATACG GGATACATATACAGTAGAGACCAGTGGGATCCTGAAGTCATTGAGAATCATAGGAAAAAGAAGAAAGAAGCCCAAAAGGACGGAAAAGGA GAAGAGGAAGAAGAGGAAGAAGAGCAAGAAGAAGAAGAGGCATTTATTGCCGAAATGCAGATGGTGGCTGAAATTCTTCATCATCTAGTT CAGAGGCCTGAAGATTATTTGGAAAATGTTGAAAACATTGTTAAGCTTTATAAGGAAACAATTCTCCAAACTTTAGAAGAAGTAATGGCT GAACACAATCCCCAGTATCTCATTGAGCTAAATGGAAATAAACCAGCAGAGGAGCTCTTTATGATTGTTATGGATCGACTTAAATATCTG AACCTAAAAAGAGCAGCTATTCTAACCAAACTTCAGGGTGCAGAGGAAGAAATTAATGACACAATGGAAAATGATGAGCTATTTCGTACT CTTGCATCTTATAAACTTATTGCACCAAGATACAGATGGCAAAGAAGTAAATGGGGACGTACATGTCCTGTGAATTTAAAAGATGGTAAC ATTTATTCAGGATTACCAGATTATTCTGTGAGTTTTCTAGGTAAAATCTACTGTCTTTCATCAGAAGAAGCATTAAAACCATTTTTGTTG AACCCACGTCCCTATCTGCTTCCACCTATGCCAGGACCACCATGTAAAGTATTCATACTTGGACCTCAATATTCAGGGAAAACAACACTT TGCAATATGCTTGCAGAAAATTACAAAGGAAAGGTAGTCGACTATGCCCAACTTGTTCAGCCACGTTTTGATAAAGCCCGTGAAACATTA GTAGAAAATACCATAGCTGAGGCCACTGCAGCAGCAATTAAAGTTGTGAAAGAAAAGCTTCTCAGGGAACTGCAAGCTAGAAAACAAGCT GAAACAGCTTTAAGAGAATTTCAAAGGCAATATGAAAAAATGGAGTTTGGAGTATTCCCAATGGAGGCAACACACTCATCAATTGATGAA GAAGGGTACATTCAAGGCTCCCAAAGGGACAGAGGCAGCTCTTTAGTGGACACCGAAGAAGCCAAAACAAAGTCAGAAAATGTCCTCCAT GATCAAGCTGCTAAAGTTGATAAAGATGATGGAAAAGAAACTGGTGAAACATTCACATTTAAAAGGCATTCTCAAGATGCTAGTCAAGAT GTAAAGTTGTATTCAGATACAGCCCCAACAGAAGACTTGATAGAAGAGGTAACTGCAGATCATCCAGAGGTTGTGACCATGATTGAAGAG ACTATAAAAATGTCACAGGATATAAACTTTGAACAGCCATATGAAAAACATGCTGAAATCTTACAGGAAGTCCTTGGAGAGGTAATGGAA GAAAACAAGGATAGGTTTCCTGGTGCCCCAAAATATGGAGGCTGGATTGTGGACAACTGCCCTATTGTAAAAGAATTGTGGATGGCCTTA ATCAAGAAAGGAATTATACCTGATTTGGTCATCTATTTATCAGATACAGAAAACAATGGAAAATGTTTATTTAATAGAATATATTTACAG AAGAAATCTGAAATTGACTCTAAGATTTTAGAAAGATTATTAGAAGAACTACAAAAGAAAAAAAAAGAAGAAGAAGAAGCAAGAAAAGCC ACAGAAGAGGAATTGAGACTCGAAGAAGAAAATCGAAGGCTACTGGAACTTATGAAAGTGAAGGCAAAAGAAGCTGAAGAGACTGATAAT GAGGATGAAGAGGAGATTGAAGGTGATGAGTTGGAAGTTCACGAAGAGCCTGAGGCATCTCACGATACCCGAGGGTCATGGTTACCTGAG GAGTTTGAAGCATCTGAGGTCCCTGAAACTGAGCCTGAAGCAGTATCTGAGCCTATCGAGGAAACTACAGTGGAAACAGAAATCCCAAAA GGATCCAAAGAGGGCCTGGAAATTGAAAAATTATCTGAAACAGTTGTACTACCTGAGTTTCCAGAAGACTCTTATCCTGATGTTCCCGAA ATGGAGCCATTTAAAGAGAAGATTGGTTCTTTCATCATCCTCTGGAAACAGCTAGAAGCAACAATTAGTGAGGCTTACATTAAAATTTTA AACTTGGAGATTGCTGACAGAACTCCACAGGAATTACTTCAAAAAGTAGTTGAGACTATGGAAAAACCATTTCAATATACTGCATGGGAG TTAACTGGGGAAGATTATGAGGAAGAAACAGAAGACTACCAGACTGAAGCAGAGGTTGATGAGGAGCTAGAGGAAGAGGAAGAGGAAGAG GGTGAAGATAAAATGAAGGAGAGAAAGAGGCATTTGGGAGACACAAAACACTTTTGTCCGGTGGTCCTCAAAGAAAACTTCATCCTGCAA CCAGGAAACACAGAAGAAGCAGCCAAGTATCGAGAAAAGATCTACTACTTTTCAAGTGCTGAGGCTAAAGAAAAGTTTTTGGAGCATCCT GAGGATTATGTGGCTCATGAAGAACCATTGAAGGCTCCTCCATTAAGAATATGCCTTGTCGGCCCCCAGGGCTCTGGCAAAACTATGTGT GGAAGACAGTTGGCAGAAAAATTAAACATTTTTCACATTCAGTTTGAAGAAGTTCTTCAAGAAAAACTACTACTCAAAACTGAAAAGAAA GTGGGACCTGAATTTGAGGAAGATTCTGAGAACGAGCAAGCTGCCAAACAAGAACTTGAAGAGCTTGCAATTCAGGCCAATGTCAAAGTT GAGGAAGAAAATACAAAAAAGCAGCTTCCAGAAGTACAACTTACAGAAGAAGAAGAAGTAATCAAATCAAGTCTAATGGAAAATGAGCCC TTGCCTCCTGAAATTCTTGAAGTAATTCTTTCTGAGTGGTGGCTTAAGGAACCAATACGTTCCACAGGTTTTATATTAGATGGTTTCCCA CGATATCCAGAAGAGGCCCAGTTTTTGGGAGATCGTGGATTTTTCCCAGATGCAGCTGTTTTTATACAAGTTGATGATCAAGATATTTTT GATCGCCTCCTTCCTGCCCAAATTGAAAAGTGGAAACTAAAACAAAAGAAGAAATTAGAAAGGAAGAAACTGATCAAAGACATGAAGGCA AAAATCAGGGTTGATACGATTGCTAAAAGAAGGGCTGAACTTATATTAGAGAGAGATAAAAAAAGGAGGGAGAATGTTGTTAGAGATGAT GAAGAGATTAGTGAGGAAGAACTTGAAGAAGACAATGATGATATTGAAAACATCCTTGAAGATGAGTTTCCAAAAGATGAGGAAGAGATG AGTGGCGAGGAAGATGAAGAACAGGAAACTGATGCAATTGAGCGCCTGAGAGGTGAACTAGGAGAAAAATTTGAAGCAGATACACATAAT TTACAAATAATACAGGATGAACTTGAGAGGTATTTGATACCAATAATTTCCATTAATGGAGCTCGGAGAAATCACATTGTACAATATACA TTGAATATGAAACTGAAACCACTGGTGGAAAATCGTGCAAGCATTTTTGAGAAATGTCATCCAATACCAGCACCCCTTGCCCAGAAAATG CTCACCTTTACCTACAAGTATATAAGCTCATTCGGCTATTGGGACCCTGTAAAGCTAAGTGAAGGAGAGACAATCAAGCCAGTTGAAAAT GCAGAGAATCCAATTTATCCTGTAATCCATCGTCAGTATATTTATTTTTTATCTAGTAAAGAAACAAAAGAAAAATTTATGAAGAACCCA ATCAAATATATCCGCCAACCCAAACCTAAGCCTACTGTGCCCATTAGGATTATAATTGTGGGGCCTCCAAAATCTGGGAAAACTACAGTT GCCAAAAAAATTACAAGTGAATATGGGTTAAAGCATTTATCAATAGGAGGAGCTTTGCGTTATGTACTAAACAATCACCCGGAAACAGAG CTGGCACTTATGTTAAATTGGCATCTTCATAAAGGAATGACAGCACCTGATGAACTGGCTATTCAAGCCTTAGAACTTTCTCTGATGGAA AGTGTGTGCAATACTGCAGGTGTTGTCATCGATGGATATCCTGTAACTAAACATCAAATGAATCTCTTGGAAGCTAGGTCAATCATTCCC ATGGTCATCTTTGAATTGAGTGTGCCTTCCAAGGAGATTTTCAAAAGATTGCTCCTAGAAAAAGAAAATGAACAAAGATTGCCTTATCCA TTGCACAATAGTGCACAAATTGTAGCTGTCAATAATGTAAAGTATCGCAAAAATATTGGTGAGATTAGGCAATATTATCAAGAACAGCAT CAGAACTGGTATGTGATTGATGGATTTCACAGCAAATGGTGGGTATGGAATGAAGTCATTAAGAATGTTCAAATGGTGAATAAATACATG CAGACATACCTGGAAAGAATAAAAGCAGGAAAAGCTGCCTGCATTGACAAGTTATGTATCACACCTCAAGAGCTGCTTTCTCGCCTGGGA GAATTTGAACAGTTCTGCCCTGTCAGCCTGGCAGAATCCCAGGAATTATTTGATTGCTCTGCAACTGACTCCTTGGAATTTGCAGCAGAG TTCAGGGGGCACTACTATAAAATGAGTTCTCAGGAAAAACTGAATAAATTCTTGGAGAACCCAGAATTGTACGTGCCTCCCTTAGCACCT CATCCACTCCCATCTGCTGACATGATCCCCAAAAGACTGACACTGTCAGAGCTGAAGAGTCGATTCCCTAAGTGTGCGGAGCTCCAGGGC TACTGTCCAGTGACCTATAAGGATGGAAACCAAAGATATGAAGCTCTAGTACCTGGTAGCATTAACTATGCTTTAGAATATCATAATCGT ATATATATTTGTGAGAACAAAGAAAAACTCCAGAAATTTTTGAGGTCGCCACTGAAATACTGGGAACAGAAGCTTCCACACAAGCTTCCC CCATTAAGGGAACCGATACTTCTTACTAGTCTTCCTTTGCCTGGATATCTGGAACAGGGTATTGCAACTTCTCTAATTAAAGCAATGAAT GCAGCGGGATGCTTAAAGCCCAAGTTCCCCTTTTTAAGTATAAGGAGATCTGCACTGCTATATATAGCACTTCATCTCAAAGCATTTAAT CCCAAAGGTTCCGAATACACAAGAAAAAAGTATAAGAAGAAGATGGAGCAGTTTATGGAGAGTTGTGAACTCATAACATACTTGGGTGCC AAGATGACCAGAAAATACAAGGAACCTCAGTTCAGAGCCATTGACTTTGATCATAAGTTAAAGACCTTTCTCTCTCTCAGAAATATAGAC |
* Fusion transcript sequences (Full-length transcript). |
>In-frame_ATG5_ENST00000343245_chr6_106696025_-_AK9_ENST00000424296_chr6_109980616_-_6578nt GCCCGCCCGGCCGCGATGGCGGGTGAAGGTGGTTCCTCCGGGCAAGGTGGAGTTGGCGAGACGCCGGCCCGGAGCCCTGGGGCCGGTTGG CGGGTGTGGCCTGCGGGGTCCCTCTTGGGGTACATGTCTGTTGCTTACTAAGTTTGGCTTTGGTTGAAATAAGAATTTAGCCTGTATGTA CTGCTTTAACTCCTGGAAGAATGACAGATGACAAAGATGTGCTTCGAGATGTGTGGTTTGGACGAATTCCAACTTGTTTCACGCTATATC AGGATGAGATAACTGAAAGGGAAGCAGAACCATACTATTTGCTTTTGCCAAGAGTAAGTTATTTGACGTTGGTAACTGACAAAGTGAAAA AGCACTTTCAGAAGGTTATGAGACAAGAAGACATTAGTGAGATATGGTTTGAATATGAAGGCACACCACTGAAATGGCATTATCCAATTG GTTTGCTATTTGATCTTCTTGCATCAAGTTCAGCTCTTCCTTGGAACATCACAGTACATTTTAAGAGTTTTCCAGAAAAAGACCTTCTGC ACTGTCCATCTAAGGATGCAATTGAAGCTCATTTTATGTCATGTATGAAAGAAGCTGATGCTTTAAAACATAAAAGTCAAGTAATCAATG AAATGCAGAAAAAAGATCACAAGCAACTCTGGATGGGATTGCAAAATGACAGATTTGACCAGTTTTGGGCCATCAATCGGAAACTCATGG AATATCCTGCAGAAGAAAATGGATTTCGTTATATCCCCTTTAGAATATATCAGTGTCCTGACTATGATTTGTGCCAGAGAATTTCTGGGC AAAGACAGCACAATAATACGGGATACATATACAGTAGAGACCAGTGGGATCCTGAAGTCATTGAGAATCATAGGAAAAAGAAGAAAGAAG CCCAAAAGGACGGAAAAGGAGAAGAGGAAGAAGAGGAAGAAGAGCAAGAAGAAGAAGAGGCATTTATTGCCGAAATGCAGATGGTGGCTG AAATTCTTCATCATCTAGTTCAGAGGCCTGAAGATTATTTGGAAAATGTTGAAAACATTGTTAAGCTTTATAAGGAAACAATTCTCCAAA CTTTAGAAGAAGTAATGGCTGAACACAATCCCCAGTATCTCATTGAGCTAAATGGAAATAAACCAGCAGAGGAGCTCTTTATGATTGTTA TGGATCGACTTAAATATCTGAACCTAAAAAGAGCAGCTATTCTAACCAAACTTCAGGGTGCAGAGGAAGAAATTAATGACACAATGGAAA ATGATGAGCTATTTCGTACTCTTGCATCTTATAAACTTATTGCACCAAGATACAGATGGCAAAGAAGTAAATGGGGACGTACATGTCCTG TGAATTTAAAAGATGGTAACATTTATTCAGGATTACCAGATTATTCTGTGAGTTTTCTAGGTAAAATCTACTGTCTTTCATCAGAAGAAG CATTAAAACCATTTTTGTTGAACCCACGTCCCTATCTGCTTCCACCTATGCCAGGACCACCATGTAAAGTATTCATACTTGGACCTCAAT ATTCAGGGAAAACAACACTTTGCAATATGCTTGCAGAAAATTACAAAGGAAAGGTAGTCGACTATGCCCAACTTGTTCAGCCACGTTTTG ATAAAGCCCGTGAAACATTAGTAGAAAATACCATAGCTGAGGCCACTGCAGCAGCAATTAAAGTTGTGAAAGAAAAGCTTCTCAGGGAAC TGCAAGCTAGAAAACAAGCTGAAACAGCTTTAAGAGAATTTCAAAGGCAATATGAAAAAATGGAGTTTGGAGTATTCCCAATGGAGGCAA CACACTCATCAATTGATGAAGAAGGGTACATTCAAGGCTCCCAAAGGGACAGAGGCAGCTCTTTAGTGGACACCGAAGAAGCCAAAACAA AGTCAGAAAATGTCCTCCATGATCAAGCTGCTAAAGTTGATAAAGATGATGGAAAAGAAACTGGTGAAACATTCACATTTAAAAGGCATT CTCAAGATGCTAGTCAAGATGTAAAGTTGTATTCAGATACAGCCCCAACAGAAGACTTGATAGAAGAGGTAACTGCAGATCATCCAGAGG TTGTGACCATGATTGAAGAGACTATAAAAATGTCACAGGATATAAACTTTGAACAGCCATATGAAAAACATGCTGAAATCTTACAGGAAG TCCTTGGAGAGGTAATGGAAGAAAACAAGGATAGGTTTCCTGGTGCCCCAAAATATGGAGGCTGGATTGTGGACAACTGCCCTATTGTAA AAGAATTGTGGATGGCCTTAATCAAGAAAGGAATTATACCTGATTTGGTCATCTATTTATCAGATACAGAAAACAATGGAAAATGTTTAT TTAATAGAATATATTTACAGAAGAAATCTGAAATTGACTCTAAGATTTTAGAAAGATTATTAGAAGAACTACAAAAGAAAAAAAAAGAAG AAGAAGAAGCAAGAAAAGCCACAGAAGAGGAATTGAGACTCGAAGAAGAAAATCGAAGGCTACTGGAACTTATGAAAGTGAAGGCAAAAG AAGCTGAAGAGACTGATAATGAGGATGAAGAGGAGATTGAAGGTGATGAGTTGGAAGTTCACGAAGAGCCTGAGGCATCTCACGATACCC GAGGGTCATGGTTACCTGAGGAGTTTGAAGCATCTGAGGTCCCTGAAACTGAGCCTGAAGCAGTATCTGAGCCTATCGAGGAAACTACAG TGGAAACAGAAATCCCAAAAGGATCCAAAGAGGGCCTGGAAATTGAAAAATTATCTGAAACAGTTGTACTACCTGAGTTTCCAGAAGACT CTTATCCTGATGTTCCCGAAATGGAGCCATTTAAAGAGAAGATTGGTTCTTTCATCATCCTCTGGAAACAGCTAGAAGCAACAATTAGTG AGGCTTACATTAAAATTTTAAACTTGGAGATTGCTGACAGAACTCCACAGGAATTACTTCAAAAAGTAGTTGAGACTATGGAAAAACCAT TTCAATATACTGCATGGGAGTTAACTGGGGAAGATTATGAGGAAGAAACAGAAGACTACCAGACTGAAGCAGAGGTTGATGAGGAGCTAG AGGAAGAGGAAGAGGAAGAGGGTGAAGATAAAATGAAGGAGAGAAAGAGGCATTTGGGAGACACAAAACACTTTTGTCCGGTGGTCCTCA AAGAAAACTTCATCCTGCAACCAGGAAACACAGAAGAAGCAGCCAAGTATCGAGAAAAGATCTACTACTTTTCAAGTGCTGAGGCTAAAG AAAAGTTTTTGGAGCATCCTGAGGATTATGTGGCTCATGAAGAACCATTGAAGGCTCCTCCATTAAGAATATGCCTTGTCGGCCCCCAGG GCTCTGGCAAAACTATGTGTGGAAGACAGTTGGCAGAAAAATTAAACATTTTTCACATTCAGTTTGAAGAAGTTCTTCAAGAAAAACTAC TACTCAAAACTGAAAAGAAAGTGGGACCTGAATTTGAGGAAGATTCTGAGAACGAGCAAGCTGCCAAACAAGAACTTGAAGAGCTTGCAA TTCAGGCCAATGTCAAAGTTGAGGAAGAAAATACAAAAAAGCAGCTTCCAGAAGTACAACTTACAGAAGAAGAAGAAGTAATCAAATCAA GTCTAATGGAAAATGAGCCCTTGCCTCCTGAAATTCTTGAAGTAATTCTTTCTGAGTGGTGGCTTAAGGAACCAATACGTTCCACAGGTT TTATATTAGATGGTTTCCCACGATATCCAGAAGAGGCCCAGTTTTTGGGAGATCGTGGATTTTTCCCAGATGCAGCTGTTTTTATACAAG TTGATGATCAAGATATTTTTGATCGCCTCCTTCCTGCCCAAATTGAAAAGTGGAAACTAAAACAAAAGAAGAAATTAGAAAGGAAGAAAC TGATCAAAGACATGAAGGCAAAAATCAGGGTTGATACGATTGCTAAAAGAAGGGCTGAACTTATATTAGAGAGAGATAAAAAAAGGAGGG AGAATGTTGTTAGAGATGATGAAGAGATTAGTGAGGAAGAACTTGAAGAAGACAATGATGATATTGAAAACATCCTTGAAGATGAGTTTC CAAAAGATGAGGAAGAGATGAGTGGCGAGGAAGATGAAGAACAGGAAACTGATGCAATTGAGCGCCTGAGAGGTGAACTAGGAGAAAAAT TTGAAGCAGATACACATAATTTACAAATAATACAGGATGAACTTGAGAGGTATTTGATACCAATAATTTCCATTAATGGAGCTCGGAGAA ATCACATTGTACAATATACATTGAATATGAAACTGAAACCACTGGTGGAAAATCGTGCAAGCATTTTTGAGAAATGTCATCCAATACCAG CACCCCTTGCCCAGAAAATGCTCACCTTTACCTACAAGTATATAAGCTCATTCGGCTATTGGGACCCTGTAAAGCTAAGTGAAGGAGAGA CAATCAAGCCAGTTGAAAATGCAGAGAATCCAATTTATCCTGTAATCCATCGTCAGTATATTTATTTTTTATCTAGTAAAGAAACAAAAG AAAAATTTATGAAGAACCCAATCAAATATATCCGCCAACCCAAACCTAAGCCTACTGTGCCCATTAGGATTATAATTGTGGGGCCTCCAA AATCTGGGAAAACTACAGTTGCCAAAAAAATTACAAGTGAATATGGGTTAAAGCATTTATCAATAGGAGGAGCTTTGCGTTATGTACTAA ACAATCACCCGGAAACAGAGCTGGCACTTATGTTAAATTGGCATCTTCATAAAGGAATGACAGCACCTGATGAACTGGCTATTCAAGCCT TAGAACTTTCTCTGATGGAAAGTGTGTGCAATACTGCAGGTGTTGTCATCGATGGATATCCTGTAACTAAACATCAAATGAATCTCTTGG AAGCTAGGTCAATCATTCCCATGGTCATCTTTGAATTGAGTGTGCCTTCCAAGGAGATTTTCAAAAGATTGCTCCTAGAAAAAGAAAATG AACAAAGATTGCCTTATCCATTGCACAATAGTGCACAAATTGTAGCTGTCAATAATGTAAAGTATCGCAAAAATATTGGTGAGATTAGGC AATATTATCAAGAACAGCATCAGAACTGGTATGTGATTGATGGATTTCACAGCAAATGGTGGGTATGGAATGAAGTCATTAAGAATGTTC AAATGGTGAATAAATACATGCAGACATACCTGGAAAGAATAAAAGCAGGAAAAGCTGCCTGCATTGACAAGTTATGTATCACACCTCAAG AGCTGCTTTCTCGCCTGGGAGAATTTGAACAGTTCTGCCCTGTCAGCCTGGCAGAATCCCAGGAATTATTTGATTGCTCTGCAACTGACT CCTTGGAATTTGCAGCAGAGTTCAGGGGGCACTACTATAAAATGAGTTCTCAGGAAAAACTGAATAAATTCTTGGAGAACCCAGAATTGT ACGTGCCTCCCTTAGCACCTCATCCACTCCCATCTGCTGACATGATCCCCAAAAGACTGACACTGTCAGAGCTGAAGAGTCGATTCCCTA AGTGTGCGGAGCTCCAGGGCTACTGTCCAGTGACCTATAAGGATGGAAACCAAAGATATGAAGCTCTAGTACCTGGTAGCATTAACTATG CTTTAGAATATCATAATCGTATATATATTTGTGAGAACAAAGAAAAACTCCAGAAATTTTTGAGGTCGCCACTGAAATACTGGGAACAGA AGCTTCCACACAAGCTTCCCCCATTAAGGGAACCGATACTTCTTACTAGTCTTCCTTTGCCTGGATATCTGGAACAGGGTATTGCAACTT CTCTAATTAAAGCAATGAATGCAGCGGGATGCTTAAAGCCCAAGTTCCCCTTTTTAAGTATAAGGAGATCTGCACTGCTATATATAGCAC TTCATCTCAAAGCATTTAATCCCAAAGGTTCCGAATACACAAGAAAAAAGTATAAGAAGAAGATGGAGCAGTTTATGGAGAGTTGTGAAC TCATAACATACTTGGGTGCCAAGATGACCAGAAAATACAAGGAACCTCAGTTCAGAGCCATTGACTTTGATCATAAGTTAAAGACCTTTC TCTCTCTCAGAAATATAGACCCAATTAATGGGTAGTTTACTTAGGTGATAGCAGCCTGAATCTCAAGAGTTATCTGAAAGTGATAGAGGG AAACTGAGAGAAGTAGATTGAAAATCTGGGCCTCTTGGAAGTACTTTTGCCTCCTGAGCAAGGTACCATGGCTGCCAGACTTCAGGTGAA CTCAAAGGTCTGCCAGCCAGGAAGGAGCACTCTTATGGAAACAAGTTTTAATACAATTTTAAAATGTATTGCTCTTTGCCTGAACTTTGA TGCTTTAACAAAATAAACATTCTATTTATAATTCCATATAGAAAAGTTAAGTGACTTATTTAATAAATGTATTATTTTCCTTTTTAACAT TTTCAGTAGAAAAGTCAGTCTCTGTTAAAATTACTCATTAAATGTTAGAAAGCTTTAAGACATTTAACATTGTTATAAATGAAACCAAAA TATGGGTTATACATTTTACATACAAAACTGTTTGTGAACTTTGTGAACATAAGATACTATCATTTTCCCAATAAAATAAATGGATTTTGC |
Top |
FusionGenePPI for ATG5_AK9 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
ATG5 | ATG12, IMPDH2, ATG16L1, ATG3, TECPR1, TKT, MAP1LC3B, MAP1LC3C, SIRT1, ELAVL1, TAB2, TAB3, WDFY3, HTT, CAV1, EXOC4, RB1CC1, FADD, WIPI2, MEOX2, VCP, KEAP1, CCHCR1, TEKT4, CAPN1, CAPN2, BCL2L1, XPO1, BCL10, SQSTM1, CALCOCO2, OPTN, BSN, IKBIP | AK9 | CUL4A, HSP90B1, RHOA, LRRC23, EXOG, C5orf34, HDAC3, TAF2, MYO9A, PRIM1 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for ATG5_AK9 |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for ATG5_AK9 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | ATG5 | C0002871 | Anemia | 1 | CTD_human |
Hgene | ATG5 | C0019209 | Hepatomegaly | 1 | CTD_human |
Hgene | ATG5 | C0023380 | Lethargy | 1 | CTD_human |
Hgene | ATG5 | C0024312 | Lymphopenia | 1 | CTD_human |
Hgene | ATG5 | C0027540 | Necrosis | 1 | CTD_human |
Hgene | ATG5 | C1262477 | Weight decreased | 1 | CTD_human |
Hgene | ATG5 | C4277682 | Chemical and Drug Induced Liver Injury | 1 | CTD_human |